These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
841 related items for PubMed ID: 22277728
41. Maternal and fetal hypothalamo-pituitary-adrenal axis: different response depends upon the mode of parturition. Ochedalski T, Lachowicz A. Neuro Endocrinol Lett; 2004 Aug; 25(4):278-82. PubMed ID: 15361817 [Abstract] [Full Text] [Related]
42. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression. Behnken A, Bellingrath S, Symanczik JP, Rieck MJ, Zavorotnyy M, Domschke K, Arolt V, Zwanzger P. Psychoneuroendocrinology; 2013 Mar; 38(3):447-54. PubMed ID: 22840287 [Abstract] [Full Text] [Related]
43. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M. Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748 [Abstract] [Full Text] [Related]
44. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity. Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Blüher M, Kratzsch J, Then Bergh F. Psychoneuroendocrinology; 2017 Apr; 78():39-47. PubMed ID: 28167369 [Abstract] [Full Text] [Related]
45. Stress responsive neurohormones in depression and anxiety. Ströhle A, Holsboer F. Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081 [Abstract] [Full Text] [Related]
46. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome. Gaab J, Engert V, Heitz V, Schad T, Schürmeyer TH, Ehlert U. J Psychosom Res; 2004 Apr; 56(4):419-24. PubMed ID: 15094026 [Abstract] [Full Text] [Related]
47. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test. Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I. Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531 [Abstract] [Full Text] [Related]
48. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression. Bschor T, Adli M, Baethge C, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M. Neuropsychopharmacology; 2002 Sep 15; 27(3):470-8. PubMed ID: 12225704 [Abstract] [Full Text] [Related]
49. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Rinne T, de Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den Brink W. Biol Psychiatry; 2002 Dec 01; 52(11):1102-12. PubMed ID: 12460693 [Abstract] [Full Text] [Related]
50. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior. Sher L. ScientificWorldJournal; 2006 Oct 31; 6():1398-404. PubMed ID: 17086345 [Abstract] [Full Text] [Related]
51. Can the DEX/CRH test or markers of oxidative stress distinguish work-related stress from major depressive disorder and normal controls? Rotvig DH, Jorgensen A, Jensen JH, Hansen AR, Eller NH, Jonsson SH, Knorr U, Klose MC, Feldt-Rasmussen U, Menke A, Poulsen HE, Bauer JØ, Jørgensen MB. Stress; 2024 Jan 31; 27(1):2353781. PubMed ID: 38823417 [Abstract] [Full Text] [Related]
52. Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Erhardt A, Ising M, Unschuld PG, Kern N, Lucae S, Pütz B, Uhr M, Binder EB, Holsboer F, Keck ME. Neuropsychopharmacology; 2006 Nov 31; 31(11):2515-22. PubMed ID: 16841071 [Abstract] [Full Text] [Related]
53. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Schroeder S, Wichers M, Klingmüller D, Höfer M, Lehmann LE, von Spiegel T, Hering R, Putensen C, Hoeft A, Stüber F. Crit Care Med; 2001 Feb 31; 29(2):310-6. PubMed ID: 11246311 [Abstract] [Full Text] [Related]
54. Gonadotropin-releasing hormone agonist in premenopausal women does not alter hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone. Gavin KM, Shea KL, Gibbons E, Wolfe P, Schwartz RS, Wierman ME, Kohrt WM. Am J Physiol Endocrinol Metab; 2018 Aug 01; 315(2):E316-E325. PubMed ID: 29631362 [Abstract] [Full Text] [Related]
55. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial. Sarubin N, Nothdurfter C, Schüle C, Lieb M, Uhr M, Born C, Zimmermannc R, Bühner M, Konopka K, Rupprecht R, Baghai TC. J Psychiatr Res; 2014 Jun 01; 53():76-83. PubMed ID: 24655586 [Abstract] [Full Text] [Related]
56. Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: a translational approach. Heinzmann JM, Kloiber S, Ebling-Mattos G, Bielohuby M, Schmidt MV, Palme R, Holsboer F, Uhr M, Ising M, Touma C. Psychoneuroendocrinology; 2014 Nov 01; 49():229-43. PubMed ID: 25123105 [Abstract] [Full Text] [Related]
57. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. Maghnie M, Uga E, Temporini F, Di Iorgi N, Secco A, Tinelli C, Papalia A, Casini MR, Loche S. Eur J Endocrinol; 2005 May 01; 152(5):735-41. PubMed ID: 15879359 [Abstract] [Full Text] [Related]
58. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine. Schmid DA, Wichniak A, Uhr M, Ising M, Brunner H, Held K, Weikel JC, Sonntag A, Steiger A. Neuropsychopharmacology; 2006 Apr 01; 31(4):832-44. PubMed ID: 16237393 [Abstract] [Full Text] [Related]
59. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests. Menke A, Arloth J, Best J, Namendorf C, Gerlach T, Czamara D, Lucae S, Dunlop BW, Crowe TM, Garlow SJ, Nemeroff CB, Ritchie JC, Craighead WE, Mayberg HS, Rex-Haffner M, Binder EB, Uhr M. Psychoneuroendocrinology; 2016 Jul 01; 69():161-71. PubMed ID: 27107207 [Abstract] [Full Text] [Related]
60. Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls. Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgieß J, Blüher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O. Stress; 2019 Jan 01; 22(1):93-102. PubMed ID: 30369292 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]